Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Incompetent CEO

<< Previous

Bullboard Posts

Next >>

Comment by Forestviewon Mar 05, 2021 12:41pm

126 Views

Post# 32729070

RE:Incompetent CEO

I don't disagree with any of this. The science is sound, but I've been vocal of late of my distrust of Dan to execute. He's done some shady things, and hasn't won my trust back. Though his letter back to Marky contained some good advice (I check this stock daily, I need to stop, it's causing me stress), his words are meaningless to me as this stock has just been mired in poor execution, and I'm seriously worried that we will never hit the big jackpot becuase of it.

Layth1990 wrote:
Everything were excuted in a sh**y way. In askbio, Dan said no dilution and then he did "bought deal" which ruined the nuance momentum. Also, we still have probably another dilution for IP With holding. He screwed as well anyone who invested with the bought deal which was at 6cad.

now they are adding after screwing the momentum and probably ip dilution will come at cheap prices for him and wallace. So much manipulation, i lost interest in ate because of what i mentioned above. We have a great product but not the right ceo and directors. I don't think they will get the company to the right valuation because of their greed.

i don't thinjwe will have another partners because they did dilute us which means no future partners for funding.

oh why reverse split if not you are not uplistong on nasdaq ? What are you doing? You gave us a morohine shot by upgrading the OTC. What a joke

you have no excuse for more delays. Us cases are way to down from 400k to 60k.i'm sure you will come up with something.

we need someone who gets things done, honest and with integrity. Your greed will kill everyone and this beautiful platform